Tracking Medicare news, policy, and coverage changes.
Spero Therapeutics enters immunology with an antibody licensed from Innovent Biologics. The lead indication is a rare autoimmune condition where Spero aims to offer advantages over the Amgen drug that is currently the only approved treatment. The post After Antibiotic Approval, Spero Pivots to Immunology Aiming to Rival an Amgen Asset appeared first on MedCity News .
Read full article →The FTC settled a lawsuit against CVS Caremark over allegations that the company artificially inflated the price of insulin and impeded access to the diabetes treatment.
Read full article →Prescription drugs purchased under a controversial government discount program amounted to $100 billion in 2025, a 22.8% increase from the previous year.
Read full article →A surge of cases of the intestinal illness that causes diarrhea and fatigue has been detected in 34 states. Here's how what to do if you suspect you have it and how to avoid infection.
Read full article →